AstraZeneca reported 2.88B in EBIT for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbvie ABBV:US $ 5029M 601M
Alcon AG ALC:SW 303M 148M
Amgen AMGN:US $ 2500M 196M
Artemis Alpha ATS:LN -10207000 58.81M
AstraZeneca AZN:LN 2.88B 1.57B
AstraZeneca AZN:SS 2.88B 1.57B
Astrazeneca AZN:US 2.88B 1.57B
Bayer BAYN:GR 4.17B 704M
Biogen BIIB:US $ 531.5M 11.7M
Bristol Myers Squibb BMY:US $ 3188M 399M
Eli Lilly And LLY:US $ 2569.9M 171.6M
Fresenius FRE:GR 803M 160M
Fresenius Medical Care FME:GR 433.18M 131.01M
Galapagos GLPG:NA -21146000 31.3M
Genmab GEN:DC 514M 295M
Gilead Sciences GILD:US $ 2897M 1957M
GlaxoSmithKline GSK:LN 2.42B 724M
GRIFOLS GRF:SM 244.2M 75.33M
H. Lundbeck A/S LUN:DC 875M 869M
Hikma Pharmaceutical HIK:LN 279M 1000K
Lonza Group LONN:SW 551M 48M
Merck MRK:GR 1.2B 186M
Merk MRK:US $ 5059M 207M
Novartis NOVN:VX 3.15B 266M
Orion ORNBV:FH 71.5M 31.6M
Pfizer PFE:US $ 9995M 4136M
Philips PHIA:NA 243M 391M
Recordati REC:IM 138.4M 8.48M
Regeneron Pharmaceuticals REGN:US $ 1286.6M 1353.1M